Panacea Biotec Limited, a leading player in the biotechnology sector, has announced the cessation of Mr. Sunil Anand, Associate Director – Finance & Corporate Affairs, from its senior management team. Mr. Anand superannuated from the services of the company on March 31, 2025, after a distinguished career of over two decades.

Reason for Change

Mr. Sunil Anand has left his position as Senior Management Personnel due to his superannuation from the company. Having served Panacea Biotec for more than 20 years, Mr. Anand played a key role in the finance and corporate affairs functions of the company. His long association with the company and substantial contributions towards its growth have left an indelible mark.

Since the change in senior management is due to superannuation, there is no resignation letter required for this transition, as outlined under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mr. Sunil Anand's Contributions

During his tenure at Panacea Biotec, Mr. Anand held critical roles and was responsible for overseeing financial operations and corporate strategy, contributing significantly to the company’s overall growth trajectory. His leadership in the company’s finance and corporate affairs functions helped steer the organization through various milestones and challenges.

Acknowledgment by the Company

The Management of Panacea Biotec expressed deep appreciation for Mr. Anand's extensive contribution and his invaluable guidance over the years. His leadership was instrumental in building and maintaining the strong financial backbone that helped the company succeed in the biotechnology industry.

Details as per SEBI LODR Regulations

Under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the following details have been disclosed regarding Mr. Anand’s cessation from the role:

1. Reason for Change: Mr. Anand ceased to be Senior Management Personnel due to superannuation.

2. Date of Cessation: March 31, 2025.

3. Brief Profile: Not Applicable, as the change is due to superannuation.

4. Disclosure of Relationships: Not Applicable, as there is no inter-se relationship with any director.

Conclusion

The cessation of Mr. Sunil Anand marks the end of a significant era for Panacea Biotec, as he played an instrumental role in shaping the company’s financial and corporate strategies over the years. The company now looks forward to continuing its journey of growth and innovation, guided by its strong leadership team.

For more information, you can reach out to Panacea Biotec via their official contact details, or visit their corporate office.

The Current active IPO are Infonative Solutions Limited,Spinaroo Commercial Limited,Retaggio Industries Limited.

The Closed IPOs are  Identixweb Limited, ATC Energies System Limited, Shri Ahimsa Naturals Limited.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.